Assessment of the safety of Qin Kai Ling injection: A systematic review

Journal of Evidence-Based Medicine

Volumn 3, Issue 2, 2010, Pages 105-116

  Hao, Yuan ^a   Kong, Xiangyu ^a   Wu, Taixiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adverse drug reaction (ADR); Adverse event (AE); Qin Kai Ling injection; Systematic review

Indexed keywords

CHINESE DRUG; QIN KAI LING; UNCLASSIFIED DRUG;

DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG SAFETY; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; INJECTION SITE IRRITATION; INJECTION SITE PAIN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SHOCK; SKIN MANIFESTATION; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 77954602646     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2010.01074.x     Document Type: Review

References (7)

1. Jianhua Yang: The clinical use of Qin Kai Ling injection. Journal of Patent Traditional Chinese Medicine 1994; 16(12): 20-21
2. State Administration of Traditional Chinese Medicine of People's Republic of China: Practice Guideline of Essential TCM Patent Drugs in Emergency Department of TCM hospitals. Beijing, Chinese Medical Publish House 1993: 28-37.
3. Xinli Lei. Observation of Qin Kai Ling injection in the use of pediatrics. Chinese Journal of Modern Traditional Chinese and Western Medicine 2004; 2(10): 916.
4. Shuli Lao. A clinical study of Qin Kai Ling injection in the treatment of pediatrics bronchitis pneumonia. Chinese Journal of Modern Pediatrics 2007; 4(1): 8-10.
5. National ADR Monitoring Center: Regulation of Drug ADR Report and Monitoring. 2009; 2, Available from: URL: http://www.cdr.gov.cn/zcfg/ypblfyzcfg/ 5639.shtml
6. Ministry of Health of People's Republic of China, State Food and Drug Administration: Measures of Drug ADR reporting and Monitoring (Regulation No. 7), Available from: URL: http://www.sda.gov.cn/WS01/CL0053/24477.html
7. Taixiang Wu, Hongcai Shang, Zhaoxiang Bian, et al. Recommendation for reporting traditional Chinese medicine adverse drug reaction. Chinese Journal of Evidence-Based Medicine 2009; 10(2): 215-219